For research use only. Not for therapeutic Use.
Paliperidone（Cat No.:A000313）is an atypical antipsychotic used to treat schizophrenia and schizoaffective disorder. It works by balancing dopamine and serotonin levels in the brain, alleviating symptoms such as hallucinations, delusions, and mood disturbances. Available in both oral and long-acting injectable forms, Paliperidone provides flexible dosing options to improve adherence and treatment outcomes. Its extended-release formulation ensures stable drug levels, reducing the frequency of dosing and enhancing patient convenience. Paliperidone’s efficacy in managing both positive and negative symptoms of psychotic disorders makes it a valuable tool in psychiatric treatment.
| Catalog Number | A000313 |
| CAS Number | 144598-75-4 |
| Synonyms | NA |
| Molecular Formula | C23H27FN4O3 |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Solubility | Limited solubility |
| Storage | 3 years -20C powder |
| IUPAC Name | 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one |
| InChI | InChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3 |
| InChIKey | PMXMIIMHBWHSKN-UHFFFAOYSA-N |
| SMILES | CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F |
